1. Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma
- Author
-
Joanna Kopecka, Francesca Cordero, Ilaria Buondonno, Massimo Serra, Federica Di Nicolantonio, Martina Godel, Deborah Morena, Claudia Maria Hattinger, Riccardo Taulli, Preeta Ananthanarayanan, Chiara Riganti, and Giulio Ferrero
- Subjects
0301 basic medicine ,Ribosome biogenesis ,Apoptosis ,lcsh:Chemistry ,0302 clinical medicine ,Tumor Cells, Cultured ,polycyclic compounds ,Small nucleolar RNA ,Cytotoxicity ,lcsh:QH301-705.5 ,Spectroscopy ,Antibiotics, Antineoplastic ,Chemistry ,chemoresistance ,General Medicine ,Chemoresistance ,Doxorubicin ,Osteosarcoma ,Small nucleolar RNAs ,Computer Science Applications ,Gene Expression Regulation, Neoplastic ,030220 oncology & carcinogenesis ,GADD45A ,medicine.drug ,small nucleolar RNAs ,DNA repair ,Bone Neoplasms ,macromolecular substances ,doxorubicin ,Article ,Catalysis ,Inorganic Chemistry ,03 medical and health sciences ,osteosarcoma ,Biomarkers, Tumor ,medicine ,Humans ,RNA, Small Nucleolar ,Physical and Theoretical Chemistry ,Molecular Biology ,Gene ,Cell Proliferation ,organic chemicals ,Organic Chemistry ,technology, industry, and agriculture ,medicine.disease ,carbohydrates (lipids) ,030104 developmental biology ,lcsh:Biology (General) ,lcsh:QD1-999 ,Drug Resistance, Neoplasm ,Cancer research - Abstract
Doxorubicin (Dox) is one of the most important first-line drugs used in osteosarcoma therapy. Multiple and not fully clarified mechanisms, however, determine resistance to Dox. With the aim of identifying new markers associated with Dox-resistance, we found a global up-regulation of small nucleolar RNAs (snoRNAs) in human Dox-resistant osteosarcoma cells. We investigated if and how snoRNAs are linked to resistance. After RT-PCR validation of snoRNAs up-regulated in osteosarcoma cells with different degrees of resistance to Dox, we overexpressed them in Dox-sensitive cells. We then evaluated Dox cytotoxicity and changes in genes relevant for osteosarcoma pathogenesis by PCR arrays. SNORD3A, SNORA13 and SNORA28 reduced Dox-cytotoxicity when over-expressed in Dox-sensitive cells. In these cells, GADD45A and MYC were up-regulated, TOP2A was down-regulated. The same profile was detected in cells with acquired resistance to Dox. GADD45A/MYC-silencing and TOP2A-over-expression counteracted the resistance to Dox induced by snoRNAs. We reported for the first time that snoRNAs induce resistance to Dox in human osteosarcoma, by modulating the expression of genes involved in DNA damaging sensing, DNA repair, ribosome biogenesis, and proliferation. Targeting snoRNAs or down-stream genes may open new treatment perspectives in chemoresistant osteosarcomas.
- Published
- 2020